Practice guideline for examination of the placenta: Developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists

Archives of Pathology and Laboratory Medicine

Volumn 121, Issue 5, 1997, Pages 449-476

  Langsten, Claire ^a   Kaplan, Cynthia ^g   Macpherson, Trevor ^b   Manci, Elizabeth ^c   Peevy, Keith ^d   Clark, Barbara ^e   Murtagh, Cathy ^e   Cox, Susan ^f   Glenn, Guy ^g  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Department of Pathology   (United States)

^d UNIVERSITY OF SOUTH ALABAMA   (United States)

^e Assoc Phys Assistants Obstet G   (United States)

^f UNIVERSITY OF TEXAS AT DALLAS   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; DISEASE ASSOCIATION; HISTOGENESIS; HUMAN; PATHOGENESIS; PLACENTA DISORDER; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; STANDARDIZATION;

HUMANS; MEDICAL RECORDS; PATHOLOGY, SURGICAL; PLACENTA; SOCIETIES, MEDICAL; SPECIMEN HANDLING; UNITED STATES;

EID: 0342547012     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Office of Quality Assurance. Attribute to Guide the Development of Practice Parameters. Chicago, III: American Medical Association; 1990.
2. College of American Pathologists Conference XIX, The Examination of the Placenta: Patient Care and Risk Management. Arch Pathol Lab Med, 1991;115: 660-721.
3. Salafia CM, Vintzileos AM. Why all placentas should be examined by a pathologist in 1990. Am J Obstet Gynecol. 1990;163:1282-1293.
4. Driscoll SG. Pathology and the developing fetus, Pediatr Clin North Am. 1965;12:493.
5. Lambird PA. Resource allocation and the cost of quality. Arch Pathol Lab Med. 1990;114:1168-1172.
6. Stiell IG, McKnight RD, Greenburg GH, et al. Implementation of Ottawa ankle rules. JAMA. 1994;271:827-832.
7. McDonald CJ, Overhage JM. Guidelines you can follow and trust: an ideal and an example. JAMA. 1994;271:872-873.
8. Naeye RL. Functionally important disorders of the placenta, umbilical cord and fetal membranes. Hum Pathol. 1987;18:680-691.
9. Driscoll SG. Placental examination in a clinical setting. Arch Pathol Lab Med. 1991;115:668-671.
10. Perrin EVDK, Sander CM. Introduction: how to examine the placenta and why. In: Perrin EVDK, ed. Contemnporary Issues in Surgical Pathology, vol 5, Pathology of the Placenta. New York, NY: Churchill Livingstone Inc; 1984:1-35.
11. Altshuler G, Herman A. Fetal and neonatal brain injury: mechanisms, management and the risks of practice. In: The Mecdicolegal Imperative: Placenta Pathology and Epidemiology. Toronto, Ontario: BC Decker: 1989:250-263.
12. Manci FA, Ulmer RD, Holland SD, D'Angelo LF, Bennett BD. Value of clinical, gross and combined criteria in selection of placentas of microscopic examination. Med Pathol. 1990;3:5.
13. Benirschke K, Kaufmann P. Pathology of the Human Placenta. 3rd ed. New York, NY: Springer-Verlag; 1995.
14. Driscoll SG, Langsten C. College of American Pathoiogists Conference XIX on the Examination of the Placenta: report of the working group on methods for placental examination. Arch Pathol Lab Med 1991;115:704-708.
15. 5. Kaplan CG. Color Atlas of Gross Placental Pathology. New York, NY: IgakuShoin; 1994.
16. Baldwin VJ. Pathology of Multiple Gestation. New York, NY; Springer-Verlag; 1993.
17. Hall JG, Froster-Iskenius UG, Allanson JE. Handbook of Normal Physical Measurements. New York, NY: Oxford University Press; 1989:432.
18. Molteni RA, Stys SJ, Battaglia FC. Relationship of fetal and placental weight in human beings: fetal/placental weight ratios at various gestational ages and birth weight distributions. J Reprod Med. 1978;21:327-334.
19. Naeye RL. Do placental weights have clinical significance? Hum Pathol. 1987;18:387-391.
20. Khong TY, Chambers HM. Alternative method of sampling placentas for the assessment of uteroplacental vasculature. J Clin Pathol. 1992;45:925-927.
21. Fox H. Pathology of the Placenta. Philadelphia, Pa: WB Saunders Co; 1978.
22. Naeye RL Disorders of the Placenta, Fetus and Neonate: Diagnosis and Clinical Significance. St Louis, Mo: Mosby Year Book; 1992.
23. Fox H. Pathology of the placenta. Clin Obstet Gynecol. 1986;13:501-519.
24. Rosai J. Ackerman's Surgical Pathology. 7th ed. St Louis, Mo: CV Mosby Co; 1989:1174-1191.
25. Gersell DJ, Kraus RF, Reffle M. Diseases of the placenta. In: Kurman R, ed. Blaustein's. Pathology of the Female Genital Tract. 3rd ed. New York, NY: Springer-Verlag; 1987:769-834.
26. Macpherson T, Szulman AE. The placenta and products of conception. In: Silverberg SG, ed. Principles and Practice of Surgical Pathology. 2nd ed. New York, NY: Churchill Livingstone Inc; 1990:1825-1856.
27. Pryse-Davies J, Dewhurst CJH, Campbell S. Placenta membranacea. J Obstet Gynaecol Br Commonw. 1973;80:1106-1110.
28. Hurley VA, Beischer NA. Placenta membranacea; case reports. Br J Obstet Gynaecol. 1987;94:798-802.
29. Fox H, Sen DK. Placenta extrachorialis: a clinicopathological study. J Obstet Gynaecol Br Commonw. 1972;79:32-35.
30. Fujikura T, Benson RC, Driscoll SG. The bipartite placenta and its clinical features. Am J Obstet Gynecol. 1970;107:1013-1017.
31. Fox H. Placenta accreta, 1945-1969. Obstet Gynecol Surg. 1972;27:475- 490.
32. McShane PM, Heyl PS, Epstein MF. Maternal and perinatal morbidity resulting from placenta previa. Obstet Gynecol. 1985;65:176-182.
33. Naeye RL. Placenta previa, predisposing factors and effects on the fetus and surviving infants. Obstet Gynecol. 1978;52:521 -525.
34. Froehlich LA, Fujikura J. Significance of a single umbilical artery: report for the collaborative study of cerebral palsy. Am J Obstet Gynecol. 1966;94:274- 279.
35. Soma H. Single umbilical artery with congenital malformations. Curr Top Pathol 1979;66:159-173.
36. Abuhamad AZ, Shaffer W, Mari G, Copel JA, Hobbins JC, Evans AT. Single umbilical artery: does it matter which artery is missing? Am J Obstet Gynecol. 1995;173:728-732.
37. DeSa DJ. Diseases of the umbilical cord. In: Perrin EVDK, ed. Pathology of the Placenta. New York, NY: Churchill Livingstone Inc; 1984:121-139.
38. Uyanwah-Akporm P, Fox H. The clinical significance of marginal and velamentous insertion of the cord. Br J Obstet Gynaecol. 1977;84:941-943.
39. Naeye RL. Umbilical cord length significance. J Pediatr, 1985;107:278- 281.
40. Rayburn WF, Beynen A, Brinkman DL. Umbilical cord length and intrapartum complications. Obstet Gynecol. 1981;57:450-452.
41. Wolfman WL, Purohit DM, Sally ES. Umbilical vein thrombosis at 32 weeks' gestation with delivery of a living infant. Am J Obstet Gynecol. 1983;146: 468-470.
42. Eggens JJH, Bruinse HW. An unusual case of fetal distress. Am J Obstet Gynecol, 1984;148:219-220.
43. Altshuler G, Hyde S. Meconium induced vasoronstriotion: a potential cause of cerebral and other fetal hypoperfusion and of poor pregnancy outcome. J Child Neurol. 1989;4:137-142.
44. Altshuler G. The placenta. In: Sternberg SS, ed. Diagonostic Surgical Pathology. 3rd ed. New York. NY: Raven Press; 1994:1993-2015.
45. Naeye RL, Ross SM. Amniotic: fluid infection syndrome. Clin Obstet Gynecol. 1982;9:593-607.
46. Naeye RL, Peters EC. Amniotic fluid infection with intact membranes leading to perinatal death: a prospective study. Pediatrics, 1970;171:171-177.
47. Blanc WA. Pathology of the placenta, membranes and umbilical cord in bacterial, fungal and viral infections in man. In: Naeye Rl, Caisson JM, Kaufmann N, eds. Perinatal Disease. Baltimore, Md: Williams & Wilkins; 1981:67.
48. Abramowsky CR, Vegas ME, Swinehart G, Gyves MT. Decidual vasculopathy of the placenta in lupus erythematosus. N Engl Med. 1980;303:668-672.
49. Wentworth P. A placental lesion to account for foetal haemorrhage into the maternal circulation. J Obstet Gynaecol Br Commonw. 1964;71:379-387.
50. Sibai BM, Taslimi MN. el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol. 1986;155:501-509.
51. Paterson MEL. The etiology and outcome of abruptio placentae. Acta Obstet Gynecol Scand. 1979;58:31-33.
52. Benirschke K, Kaufmann P. The pathology of maternal floor infarction. In: Pathology of the Human Placenta. New York, NY: Springer-Verlag; 1990:406- 411.
53. Naeye RL. Maternal floor infarction. Hum Pathol. 1985;16:823-828.
54. Shanklin DR, Scott JS. Massive subchorial thrombohematoma (Breus moles) Br J Obstet Gynaecol. 1973;82:476-487.
55. Sander CM, Stevens NG, Hemorrhagic endovasculitis of the placenta: an in depth morphologic appraisal with initial clinical and eptdemiologic observations. Pathol Annu. 1984;37-79.
56. Fox H. Thrombosis of foetal arteries in the human placenta. Br J Obstet Gynaecol. 1966;73:961-965.
57. Naeye RL, Maisels J, Lorenz RP, Botti JJ. The clinical significance of placental villous edema. Pediatrics. 1985;71:588-594.
58. Shen-Schwarz S, Ruchelli E, Brown D. Villous edema of the placenta: a clinicopathological study. Placenta. 1989;10:297-307.
59. Salafia CM, Weigl CA, Foye GJ. Correlation og placental erythrocyte morphology and gestational age. Pediatir Pathol. 1988;8:8:495-502.
60. Baldwin VJ. Pathology of multiple pregnancy. In: Dimmick JE, Kalousek DK, eds. Developmental Pathology of the Embryo and Fetus. Philadelphia, Pa: JB Lippincott Co; 1992:320.
61. National Research Council. Biosafety in the Laboratory: Prudent Practices for the Handling and Disposal of Infectious, Material. Washington, DC: National Academy Press; 1989.
62. Recommendations for prevention of HIV transmission in Healthcare settings. MMWR. 1987:36(Suppl 2):3S-18S.
63. Update: universal precautions for prevention of transmission of human imnumodeficiency virus, hepatitis B, and other bloodborne pathogens in health care settings. MMWR. 1988;37:377-388.
64. Richmond JY, McKinney RW, eds. Biosafety in Microbiological and Biomedical Laboratories. 3rd ed. Atlanta, Ga: Centers for Disease Control: 1993. US Dept of Health and Human Services publication 93-8395.
65. Protection of Laboratory Workers from Infectious Disease Transmitted by Blood, Body Fluids, and Tissue. 2nd ed. Villanova, Pa: National Committee on Clinical Laboratory Standards: 1991 NCCLS document M29-T2.
66. US Department of Labor, Occupational Safety and Health Administration Occupational exposure to blood borne pathogens, final rule, Federal Register. 1991;56:64175-64182.